Jalra-M 50mg/500mg Tablet
Jalra-M 50mg/500mg Tablet
Metformin (500mg) + Vildagliptin (50mg)
Eveglip-M Tablet
Eleveton Pharma
Vildagliptin 50mg
Pack Size
strip of 10 tablets
Price
Save ₹201
that's 79% off!
About This Medicine
Product description & overview
Jalra-M 50mg/500mg Tablet: A Dual-Action Diabetes Management Solution
Jalra-M is a combined tablet containing Metformin (500mg) and Vildagliptin (50mg), formulated for the management of Type 2 diabetes. This precise dosage combination helps to control blood sugar levels by regulating insulin activity and inhibiting glucagon secretion.
Key Benefits:
* Improved Glycemic Control: Jalra-M effectively lowers fasting glucose and HbA1c levels, leading to better glycemic control in individuals with Type 2 diabetes.
* Convenient Dosage: The combined tablet form provides a convenient dosage solution for daily use.
* Proven Efficacy: Metformin is a first-line therapy for type 2 diabetes, while Vildagliptin enhances its effectiveness by controlling glucagon levels.
Use Under Medical Supervision: Always consult with your healthcare professional before starting Jalra-M to ensure proper dosage and suitability. This medication should be used as part of a comprehensive management plan that may also include lifestyle modifications and regular blood sugar monitoring.
Important Note: This product description is for informational purposes only and does not substitute professional medical advice. Always consult with your physician or healthcare provider before using this medication.
Active composition
Vildagliptin 50 mg
+1 more active ingredient
About Vildagliptin
Vildagliptin is an anti-diabetic medication used to treat type 2 diabetes. It works by inhibiting the DPP-4 enzyme, which increases incretin levels and enhances insulin secretion. Vildagliptin is effective in managing blood sugar levels. Common side effects may include headache and nasopharyngitis, but these usually resolve over time. In summary, Vildagliptin is important for managing diabetes.
How It Works
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jalra-M 50mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jalra-M 50mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jalra-M 50mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jalra-M 50mg/500mg Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jalra-M 50mg/500mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jalra-M 50mg/500mg Tablet